|
1
|
Weisblum Y, Panet A, Zakay-Rones Z,
Haimov-Kochman R, Goldman-Wohl D, Ariel I, Falk H, Natanson-Yaron
S, Goldberg MD, Gilad R, Lurain NS, Greenfield C, Yagel S and Wolf
DG: Modeling of human cytomegalovirus maternal-fetal transmission
in a novel decidual organ culture. J Virol. 85:13204–13213. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reuter JD, Gomez DL, Wilson JH and Van Den
Pol AN: Systemic immune deficiency necessary for cytomegalovirus
invasion of the mature brain. J Virol. 78:1473–1487. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Imai Y, Shum C, Martin DF, Kuppermann BD,
Drew WL and Margolis TP: Emergence of drug-resistant
cytomegalovirus retinitis in the contralateral eyes of patients
with AIDS treated with ganciclovir. J Infect Dis. 189:611–615.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li S, Zhu J, Zhang W, Chen Y, Zhang K,
Popescu LM, Ma X, Lau WB, Rong R, Yu X, et al: Signature microRNA
expression profile of essential hypertension and its novel link to
human cytomegalovirus infection. Circulation. 124:175–184. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang ZR, Yu LP, Yang XC, Zhang F, Chen
YR, Feng F, Qian XS and Cai J: Human cytomegalovirus linked to
stroke in a Chinese population. CNS Neurosci Ther. 18:457–460.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shankar TN, Shantha NV, Ramesh HP, Murthy
IA and Murthy VS: Toxicity studies on turmeric (Curcuma longa):
Acute toxicity studies in rats, guineapigs & monkeys. Indian J
Exp Biol. 18:73–75. 1980.PubMed/NCBI
|
|
7
|
Vallee F, Carrez C, Pilorge F, Dupuy A,
Parent A, Bertin L, Thompson F, Ferrari P, Fassy F, Lamberton A,
Thomas A, et al: Tricyclic series of heat shock protein 90 (Hsp90)
inhibitors part I: Discovery of tricyclic imidazo [4,5-c] pyridines
as potent inhibitors of the Hsp90 molecular chaperone. J Med Chem.
54:7206–7219. 2011. View Article : Google Scholar
|
|
8
|
Stolina M, Sharma S, Lin Y, Dohadwala M,
Gardner B, Luo J, Zhu L, Kronenberg M, Miller PW, Portanova J, et
al: Specific inhibition of cyclooxygenase 2 restores antitumor
reactivity by altering the balance of IL-10 and IL-12 synthesis. J
Immunol. 164:361–370. 2000. View Article : Google Scholar
|
|
9
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lv YL, Lan AJ, Lan YY, Li C, Lei N, Wu C
and Liu LH: Activity of curcumin against human cytomegalovirus in
vitro. Afr J Pharm Pharmacol. 6:30–35. 2012.
|
|
11
|
Austen M and Dohrmann C: Phenotype-first
screening for the identification of novel drug targets. Drug Discov
Today. 10:275–282. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu XC, Chi XH, Yang B, Zhu HL, Liu LH,
Zhang F and Yan JW: Gene expression profile analysis of T
lymphocytes involved in pathogenesis of severe aplastic anemia by
using bioinformatics method as a novel way of drug screening.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 18:416–420. 2010.In Chinese.
PubMed/NCBI
|
|
13
|
Yang B, Lu XC, Liu LH, Zhu HL, Chi XH, Yao
SQ, Lou FD and Yu L: Experimental identification of drugs with
function of targeted up-regulating ID4 expression:
Bioinformatics-based prediction and preliminary validation.
Zhonghua Yi Xue Za Zhi. 89:1714–1716. 2009.In Chinese. PubMed/NCBI
|
|
14
|
Burch AD and Weller SK: Herpes simplex
virus type 1 DNA polymerase requires the mammalian chaperone hsp90
for proper localization to the nuleus. J Virol. 79:10740–10749.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Grenert JP, Sullivan WP, Fadden P,
Haystead TA, Clark J, Mimnaugh E, Krutzsch H, Ochel HJ, Schulte TW,
Sausville E, et al: The amino-terminal domain of heat shock protein
90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that
regulates hsp90 conformation. J Biol Chem. 272:23843–23850. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Geller R, Andino R and Frydman J: Hsp90
inhibitors exhibit resistance-free antiviral activity against
respiratory syncytial virus. PLoS One. 8:e567622013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng CF, Fan J, Zhao ZW, Woodley DT and
Li W: Secreted heat shock protein-90a: A more effective and safer
target and for anti-cancer drags. Curr Signal Tranduction Ther.
5:121–127. 2010. View Article : Google Scholar
|
|
18
|
Zhai QQ, Luo Y, Wang QD, Xia M, Xing GW,
Li YC, Jiang JH, Liu Z, Liu QY, Wang YF, et al: Determination of
SNX-2112, a selective Hsp90 inhibitor, in plasma samples by
hish-performance liquid chromatography and its application to
pharmacokineties in rats. J Pharm Biomed Anal. 53:1048–1052. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang S QL, Zhou F, Huang J, Guo Y and
Yang K: Molecular cloning and expression analysis of a heat shock
protein (Hsp90) gene from black tiger shrimp (Penaeus monodon). Mol
Biol Rep. 36:127–134. 2009. View Article : Google Scholar
|
|
20
|
Meng S SG and Li ZR: Recent progress in
the study of Hsp90 inhibitors. Chin J Antibiot. 36:241–248.
2011.
|
|
21
|
Wen KW and Damania B: Hsp90 and
Hsp40/Erdj3 are required for the expression and anti-apoptotic
function of KSHV K1. Oncogene. 29:3532–3544. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsou YL, Lin YW, Chang HW, Lin HY, Shao
HY, Yu SL, Liu CC, Chitra E, Sia C and Chow YH: Heat shock protein
90: Role in enterovirus 71 entry and assembly and potential target
for therapy. PLoS One. 8:e771332013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Murata T, Iwata S, Siddiquey MN, Kanazawa
T, Goshima F, Kawashima D, Kimura H and Tsurumi T: Heat shock
protein 90 inhibitors repress latent membrane protein 1 (LMP1)
expression and proliferation of Epstein-Barr virus-positive natural
killer cell lymphoma. PLoS One. 8:e635662013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo Y, Lou S, Deng X, Liu Z, Li Y,
Kleiboeker S and Qiu J: Parvovirus B19 infection of human primary
erythroid progenitor cells triggers ATR-Chk1 signaling, which
promotes B19 virus replication. J Virol. 85:8046–8055. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Geller R, Vignuzzi M, Andino R and Frydman
J: Evolutionary constraints on chaperone-mediated folding provide
an antiviral approach refractory to development of drug resistance.
Genes Dev. 21:195–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Turnell AS and Grand RJ: DNA viruses and
the cellular DNA-damage response. J Gen Virol. 93:2076–2097. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiao A, Wong J and Luo H: Viral
interaction with molecular chaperones: Role in regulating viral
infection. Arch Virol. 155:1021–1031. 2010. View Article : Google Scholar : PubMed/NCBI
|
